[
    [
        {
            "time": "",
            "original_text": "股东清仓式减持老百姓大药房套现50亿元：药店零售变局中的危与机 减持股份",
            "features": {
                "keywords": [
                    "清仓式减持",
                    "老百姓大药房",
                    "套现",
                    "药店零售",
                    "危与机"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "零售"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "股东清仓式减持老百姓大药房套现50亿元：药店零售变局中的危与机 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "第二大股东西清仓式减持，老百姓（603883.SH）怎么了？ 减持股份",
            "features": {
                "keywords": [
                    "第二大股东",
                    "清仓式减持",
                    "老百姓",
                    "减持股份"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "第二大股东西清仓式减持，老百姓（603883.SH）怎么了？ 减持股份",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业2019年中报业绩前瞻:医药板块持续分化,寻找景气与避险的交集",
            "features": {
                "keywords": [
                    "医药生物行业",
                    "2019年中报",
                    "业绩前瞻",
                    "医药板块",
                    "持续分化",
                    "景气与避险"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业2019年中报业绩前瞻:医药板块持续分化,寻找景气与避险的交集",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        }
    ]
]